Insmed Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Buy

61

INSM
Insmed

Last Price:

72.22

Seasonality Move:

4.27%

Sell

42

NBY
NovaBay Pharmaceuticals

Last Price:

0.71

Seasonality Move:

-22.66%

Buy

61

Insmed (INSM) is a Buy

Is Insmed a Buy, Sell or Hold?

The current Insmed [INSM] share price is $71.40. The Score for INSM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
INSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

42

NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

The current NovaBay Pharmaceuticals [NBY] share price is $0.74. The Score for NBY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

INSM Stock Price Chart

What is Insmed's stock price today?

The Insmed share price today is $71.40
The current trend is moderately bearish and INSM is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

The NovaBay Pharmaceuticals share price today is $0.74
The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

INSM Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.44	Sell
Relative Strength Index (14 RSI):	42.48	Sell
Chaikin Money Flow:	-861581	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(71.87 - 74.63)	Sell
Bollinger Bands (100):	(50.82 - 81.14)	Buy

NBY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.02	Buy
Relative Strength Index (14 RSI):	59.35	Buy
Chaikin Money Flow:	187356	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.45 - 0.69)	Buy
Bollinger Bands (100):	(0.35 - 3.13)	Sell

INSM Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	72.62	Sell
20-day SMA:	72.85	Sell
50-day SMA:	74.03	Sell
200-day SMA:	46.81	Buy
8-day EMA:	72.6	Sell
20-day EMA:	73.12	Sell
50-day EMA:	71.91	Sell
200-day EMA:	52.94	Buy

NBY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.7	Buy
20-day SMA:	0.6	Buy
50-day SMA:	0.58	Buy
200-day SMA:	3.33	Sell
8-day EMA:	0.69	Buy
20-day EMA:	0.64	Buy
50-day EMA:	0.87	Sell
200-day EMA:	7.62	Sell

Insmed Earnings Growth & INSM Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $1.08 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Insmed Technical Analysis

	Sep 20	Sep 23	Sep 24	Sep 25	Sep 26	Sep 27	Sep 30	Oct 1	Oct 2	Oct 3
	Sep								Oct
	20	23	24	25	26	27	30	01	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

	Sep 20	Sep 23	Sep 24	Sep 25	Sep 26	Sep 27	Sep 30	Oct 1	Oct 2	Oct 3
	Sep								Oct
	20	23	24	25	26	27	30	01	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):